On Dec. 13, a trio of bipartisan Congressmen penned a letter calling for an investigation into the FDA's handling recently of a drug that was denied approval for terminal prostate cancer patients. The letter raises serious questions concerning unethical behavior at the FDA and should infuriate every American.
Sunday, December 23, 2007
The FDA's handling of proposed cancer drug defies compassion
On Dec. 13, a trio of bipartisan Congressmen penned a letter calling for an investigation into the FDA's handling recently of a drug that was denied approval for terminal prostate cancer patients. The letter raises serious questions concerning unethical behavior at the FDA and should infuriate every American.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment